Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein

Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein We previously obtained a chimeric Friend murine leukemia virus (FMLV) envelope protein (Env) in which the whole receptor-binding domain (RBD) was replaced with a surface domain of human CD4. Here, we examined if the postbinding fusion function of the CD4-Env chimera still remains to be intact. While a pseudotype MLV bearing CD4-Env showed no infectivity, NIH 3T3 cells could be infected with a pseudotype MLV bearing both CD4-Env and a mutant FMLV Env defective in postbinding fusion function. The pseudotype MLV showed no infectivity on HeLa cells but on the FMLV receptor (mCAT1)-expressing HeLa cells. In NIH 3T3 cells, the R-peptide-deleted CD4-Env could not induce syncytia by itself but did so in co-operation with the fusion-deficient Env. Syncytia induced by the coexpression were not observed in HeLa cells but in the mCAT1-expressing HeLa cells. These results indicate that the CD4-Env could contribute postbinding fusion function in the membrane fusion process triggered by FMLV RBD-mCAT1 interaction. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Virology Springer Journals

Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein

Archives of Virology , Volume 146 (5) – May 1, 2001

Loading next page...
1
 
/lp/springer_journal/postbinding-fusion-function-contributed-by-a-chimeric-murine-leukemia-0og0o70ZwT

References (22)

Publisher
Springer Journals
Copyright
Copyright © 2001 by Springer-Verlag/Wien
Subject
Legacy
ISSN
0304-8608
eISSN
1432-8798
DOI
10.1007/s007050170127
Publisher site
See Article on Publisher Site

Abstract

We previously obtained a chimeric Friend murine leukemia virus (FMLV) envelope protein (Env) in which the whole receptor-binding domain (RBD) was replaced with a surface domain of human CD4. Here, we examined if the postbinding fusion function of the CD4-Env chimera still remains to be intact. While a pseudotype MLV bearing CD4-Env showed no infectivity, NIH 3T3 cells could be infected with a pseudotype MLV bearing both CD4-Env and a mutant FMLV Env defective in postbinding fusion function. The pseudotype MLV showed no infectivity on HeLa cells but on the FMLV receptor (mCAT1)-expressing HeLa cells. In NIH 3T3 cells, the R-peptide-deleted CD4-Env could not induce syncytia by itself but did so in co-operation with the fusion-deficient Env. Syncytia induced by the coexpression were not observed in HeLa cells but in the mCAT1-expressing HeLa cells. These results indicate that the CD4-Env could contribute postbinding fusion function in the membrane fusion process triggered by FMLV RBD-mCAT1 interaction.

Journal

Archives of VirologySpringer Journals

Published: May 1, 2001

There are no references for this article.